All data are based on the daily closing price as of March 6, 2026
h
Hanmi Science Co.
008930.KO
26.63 USD
0.43
+1.64%
Overview
Last close
26.63 usd
Market cap
1.80B usd
52 week high
37.77 usd
52 week low
17.04 usd
Target price
21.88 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.969
Price/Book Value
2.5537
Enterprise Value
1.68B usd
EV/Revenue
1.8497
EV/EBITDA
24.2431
Key financials
Revenue TTM
907.62M usd
Gross Profit TTM
202.07M usd
EBITDA TTM
41.94M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
1.03B usd
Net debt
85.33M usd
About
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.